The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of peripheral neuropathy (PN) using clinician- and patient-reported outcomes (ClinRO and PRO) in the POLARIX study.
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; Takeda
 
Laura Fogliatto
No Relationships to Disclose
 
Faithlore Patrice Gardner
No Relationships to Disclose
 
Ian W. Flinn
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Century Therapeutics (Inst); Genentech (Inst); Genmab (Inst); Gilead Sciences (Inst); Great Point Partners (Inst); Hutchison MediPharma (Inst); Iksuda Therapeutics (Inst); Innocare (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); MorphoSys (Inst); Novartis (Inst); Nurix (Inst); Pharmacyclics (Inst); Roche (Inst); Seagen (Inst); SERVIER (Inst); Shanghai Yingli Pharmaceuticals (Inst); Takeda (Inst); TG Therapeutics (Inst); Unum Therapeutics (Inst); Verastem (Inst); Vincerx Pharma (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Agios (Inst); ArQule (Inst); AstraZeneca (Inst); BeiGene (Inst); Bio-Path Holdings, Inc (Inst); Bristol-Myers Squibb (Inst); CALGB (Inst); CALIBR (Inst); Celgene (Inst); City of Hope (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Curis (Inst); Fate Therapeutics (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); IGM Biosciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); MorphoSys (Inst); Myeloid Therapeutics (Inst); Novartis (Inst); Nurix (Inst); Pfizer (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Rhizen Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TCR2 Therapeutics (Inst); Tessa Therapeutics (Inst); TG Therapeutics (Inst); Triact Therapeutics (Inst); Trillium Therapeutics (Inst); Unum Therapeutics (Inst); Verastem (Inst)
 
Jean-Francois Larouche
Consulting or Advisory Role - AstraZeneca Canada; Gilead Sciences
Research Funding - AstraZeneca Canada (Inst); Genmab (Inst); Incyte (Inst); Roche Canada (Inst)
 
Corinne Haioun
No Relationships to Disclose
 
Miguel Angel Canales Albendea
No Relationships to Disclose
 
Hideki Goto
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen; Kyowa Kirin; Novartis; SymBio Pharmaceuticals
 
Roman Hajek
Consulting or Advisory Role - Abbvie; Amgen; BMS; Celgene; Janssen-Cilag; Novartis; PharmaMar; Takeda
Speakers' Bureau - Amgen; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Celgene (Inst); Novartis (Inst); Takeda (Inst)
 
Gilles A. Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie; Bayer; Regeneron
Consulting or Advisory Role - Abbvie; BeiGene; BMS; Debiopharm Group; Epizyme; Genmab; Incyte; incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Miltenyi Biotec; Molecular Partners; morphosys; Nordic Nanovector; Novartis; RAPT Therapeutics; Roche/Genentech; Takeda; Velosbio
 
Jiaheng Qiu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Avrita Campinha-Bacote
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Mark Yan
No Relationships to Disclose
 
Rucha Kothari
Employment - Genentech
Stock and Other Ownership Interests - CareDX; Roche
 
Gabriel Man
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Deniz Sahin
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Jamie Hirata
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Calvin Lee
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)